OVA1 is an FDA-approved blood test that measures the levels of five proteins (CA125, transferrin, transthyretin, apolipoprotein A1, and beta-2 microglobulin) to detect ovarian cancer risk in women. Here, APOA1 is linked to ovarian carcinoma.